STOPCAP M1
Menu
  • Home
  • What is STOPCAP M1?
    • Systematic reviews
      • The FAME approach
      • Docetaxel
      • Zoledronic acid
      • Abiraterone
      • Prostate RT
      • Network
    • Surrogate outcomes
      • ICECAP M0
    • Repository of patient data
  • Who is running STOPCAP M1?
    • Programme Management Group
    • International Advisory Group
    • Key Collaborators
    • Collaborative Group
  • Patient & Public Involvement
    • PPI and STOPCAP M1
    • Recent STOPCAP M1 results
    • Prostate Cancer Resources
  • News
  • Sitemap

Sitemap

  • Home
    • What is STOPCAP M1?
      • Systematic reviews
        • The FAME approach
        • Docetaxel
        • Zoledronic acid
        • Abiraterone
        • Prostate RT
        • Network
      • Surrogate outcomes
        • ICECAP M0
      • Repository of patient data
    • Who is running the Programme?
      • Programme Management Group
      • International Advisory Group
      • Key Collaborators
      • Collaborative Group
    • Patient & Public Involvement
      • PPI and STOPCAP M1
      • Recent STOPCAP M1 results
      • Prostate Cancer Resources
    • News
    • Publications
    • Contact Us
    • Cookies
    • Protocol
  1. Home
  2. Sitemap

STOPCAP M1

MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ

Email. mrcctu.stopcapm1@ucl.ac.uk

Twitter. https://twitter.com/MRCCTU

Quick links

  • Publications
  • Protocol
Funded by PCUK

Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887.
  • © 2025
  • Sitemap
  • Cookies
  • RSS
  • Page last updated: 30-Mar-2023 15:15